Buy Ipamorelin + CJC-1295 (No DAC) 2026 — GHRP/GHRH Blend for GH Secretagogue Receptor Research (EU)
Ipamorelin + CJC-1295 (No DAC) at a glance
| Designation | Ipamorelin + CJC-1295 (No DAC) Blend |
|---|---|
| Identity | Two-component blend: Ipamorelin (pentapeptide, GHRP class) + CJC-1295 No DAC / Mod GRF 1-29 (29-amino acid peptide, GHRH analogue class) |
| Synonyms | Ipamorelin, CJC-1295, Mod GRF 1-29, GHRP, GHRH |
| Research context | GHS-R binding models (Ipamorelin), GHRH receptor binding models (CJC-1295 No DAC), in vitro |
| CAS number | Ipamorelin: 170851-70-4 · CJC-1295 (No DAC): 863288-34-0 (the batch-specific COA is authoritative) |
| Molecular formula | See CoA |
| Form | Lyophilised powder (freeze-dried), sealed vial |
| Amount | 5 mg Ipamorelin + 5 mg CJC-1295 (No DAC) per vial |
| Purity | ≥99% (HPLC), identity confirmed by LC-MS |
| Analysis | External third-party laboratory, batch-specific COA |
| Intended use | For Research Use Only (RUO) |
| Price | €74.90 · Shipping from Germany |
What is Ipamorelin + CJC-1295 (No DAC)?
This product is a Two-component blend from two different peptides that are assigned to separate substance classes. Ipamorelin is a pentapeptide and belongs to the class of growth hormone-releasing peptides (GHRPs). CJC-1295 (No DAC) – also referred to as Mod GRF 1-29 – is a 29-amino acid peptide from the GHRH analogue class. Both components are supplied as a stable lyophilised product in a sealed vial (5 mg per component). They serve as well-characterised reference substances in laboratory research. The respective CAS numbers are provided above; the molecular formulas are documented in the batch-specific certificate of analysis.
Molecular profile & target structure
The two peptides differ structurally and in their class affiliation. Ipamorelin is a short pentapeptide and is attributed in the literature to the GHRP class, whose substances in binding models at growth hormone secretagogue receptor (GHS-R) to be investigated. CJC-1295 (No DAC) is a longer 29-amino acid peptide and is derived from the N-terminal fragment of growth hormone-releasing hormone (Mod GRF 1-29); it belongs to the class of GHRH analogues assigned and characterised in binding models at the GHRH receptor. The combination of defined sequences, clear class assignment, and good analytical characterisability makes the blend a frequently referenced substance combination in the preclinical literature for receptor biochemical study models.
What in-vitro and animal model studies document
The following summary reflects only what is described in the publicly accessible preclinical literature – it is not a statement about an effect or suitability in humans.
- GHS-R binding models (Ipamorelin): Published in-vitro studies investigate Ipamorelin as a representative of the GHRP class in binding models at the GH secretagogue receptor (GHS-R).
- GHRH receptor binding models (CJC-1295 No DAC): In-vitro studies characterise CJC-1295 (No DAC) / Mod GRF 1-29 as a GHRH analogue in binding models at the GHRH receptor.
- Class assignment Literature assigns the two peptides to different substance classes – Ipamorelin to the GHRP class, and CJC-1295 (No DAC) to the GHRH analogue class.
- Reference substances: Both peptides are used as defined reference substances in receptor biochemical study models.
These observations originate from in-vitro models. They provide the basis for research interest in Ipamorelin and CJC-1295 (No DAC), but provide no information regarding safety, efficacy, or any application outside of laboratory research.
Purity, COA & Analytical Testing
Purity and identity are the two values that count – and for both components in a blend. HPLC demonstrates purity (target value ≥ 99 %), LC-MS confirms the identity of each peptide via its molecular mass. These values are listed on the batch-specific CoA. We explain how to read such a certificate in Understanding and reading a Certificate of Analysis (COA); the procedures themselves in Peptide Purity: HPLC and LC-MS Explained.
Storage & Handling
As a lyophilised product, both components are stable when stored is kept cool, dry and protected from light and stored – ideally at -20 °C for longer storage. Refer to the COA for batch-specific details. Basics: Storing and Handling Research Peptides.
Buying Ipamorelin + CJC-1295 (No DAC) in the EU – what matters
What matters is not the price, but this: Does the label match the contents? Here's what BlitzLab delivers on:
- Batch-specific COA from a third-party laboratory – HPLC (purity) and LC-MS (identity) for both components, external, not performed by ourselves.
- EU Shipping, discreetly packaged, with tracking – usually 2–5 working days.
- Transparent RUO stance – clear labelling, complete Compliance page, no claims of efficacy or cure.
What else to look out for with a reputable provider: 7-point checklist.
Frequently asked questions about buying Ipamorelin + CJC-1295 (No DAC)
Note on Sources & RUO
This guide summarises publicly available, preclinical research literature (in vitro models) on Ipamorelin and CJC-1295 (No DAC). The accompanying certificate of analysis is always decisive for the identity, CAS numbers, molecular formulas and purity of the supplied batch. All information is for informational purposes only in the research context (Research Use Only) and does not constitute medical advice, dosage or application recommendations.
Certificate of Analysis, specification, and availability directly on the product page.